Hengrui
Biotech

How Hengrui became a go-to source of China biopharma innovation

Fierce spoke to Lianshan Zhang, Ph.D., who's responsible for Hengrui's innovation ecosystem, to understand the pharma's history and its ambitions.
Leslie Zhen Liang Oct 20, 2026 8:00am
Saudi Arabia takes actionable steps to build its biotech sector after 46 agreements in Riyadh

Saudi Arabia takes actionable steps to build its biotech sector

Pfizer ADA

Pfizer makes 'business decision' to end trial of autoimmune drug

Oct 20, 2026 6:59am
From Scientific Hypothesis to Clinical Practice The Next Chapter for CLDN182

The next chapter of CLDN18.2-directed innovation

Brought to you by Astellas Pharma US
Stock market IPO share price Nasdaq

Lycia aims for $228M IPO to advance food allergy rival to Xolair

Oct 20, 2026 10:52am
Aligning drug discovery around patient benefit from the outset Connecting human insights to better decisions

Aligning drug discovery around patient benefit from the outset: Connecting human insights to better decisions

Brought to you by IQVIA Laboratories
More News

Rapport's ph. 2 bipolar mania win impresses analysts

Oct 20, 2026 9:19am

Nano24’s exosome therapy reduces respiratory failure in ph. 2

Oct 20, 2026 7:00am

AstraZeneca taps Oracle to improve recruitment for trials

Oct 20, 2026 2:36am

Ambrose inks $181M deal for former Pfizer target AM-Pharma

Oct 20, 2026 2:00am